George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,000 shares at $995.00 ($993K) on 2024-02-26, disclosed to the SEC on 2024-02-28.
Open-market sale of $992k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $990.00 | 500 | $495K | 49.9% |
| 2 | $995.00 | 500 | $498K | 50.1% |
| Total | $992.50 avg | 1,000 | $993K | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |